Compound Profiles
CJC/IPA Protocol
GHRH/GHRP Combination | Growth Hormone Optimization
CJC-1295 activates GHRH receptors via albumin-binding DAC technology for sustained elevation. Ipamorelin selectively activates ghrelin receptors (GHSR1a) without affecting ACTH/cortisol, preserving natural pulsatile GH patterns.
Ipamorelin
Growth Hormone Secretagogue | Selective GHRP
Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC/IPA Protocol with Ipamorelin?
Yes, CJC/IPA Protocol and Ipamorelin can generally be taken together. CJC/IPA Protocol and Ipamorelin amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone.
Is CJC/IPA Protocol and Ipamorelin safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.
What are the interactions between CJC/IPA Protocol and Ipamorelin?
CJC/IPA Protocol and Ipamorelin amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone. This assessment has 55% confidence and is inferred from pharmacological mechanism analysis.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.